Mr. V.c Nannapaneni.

Biography

The roots of the company are based on the founding of the NATCO (Acronym for the National Trading Company) pharmaceutical division in Kothur , Mahaboobnagar Dist, Andhra Pradesh . The generics manufacturer received a license from the Indian Patent Office for the production of sorafenibosylate in 2012 for the next eight years. The compulsory license was issued against the payment of a license fee of six percent of the sales proceeds to the patent owner Bayer AG . Instead of receiving income from the sale of the finished medicinal product, Bayer can only calculate marginal licensing fees on the subcontinent.

Research Interest

 Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.